Search Results 971-980 of 18168 for Tuberculosis

1. Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

   Clinically significant active infection (e.g. tuberculosis, viral hepatitis, HIV); Any other serious uncontrolled medical disorders or psychological ...

2. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Subject has a known active bacterial, viral, fungal, mycobacterial infection, or other infection (including tuberculosis or atypical mycobacterial disease ...

3. Helping the Girls of the Congo: Part Seven (Monday) - Mayo Clinic News Network

   Deb Rhodes rounded on the inpatient medical student service. The majority had complications from tuberculosis or HIV. When a patient needed a procedure, it was ...

4. Infectious Diseases - Clinical trials

   Rochester, Minn. Gastrointestinal (GI) infection with Campylobacter causes inflammation in the bowel and can change bacteria in the gut. Certain individuals ...

5. A Study of Healthy Donor Volunteers to Provide Blood components Via Leukapheresis for In vitro Dendritic Cell Investigations - Mayo Clinic

   No history malaria, tuberculosis, syphillis, Lyme disease, Infectious mononucleosis, Epstein‑Barr syndrome, West Nile virus, clinically evident cytomegalovirus ...

6. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

   ... tuberculosis and atypical mycobacterial disease, hepatitis B and C, herpes zoster, and HIV, but excluding fungal infections of nail beds; Vaccination with a ...

7. Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA - Mayo Clinic

   Ongoing infectious disease, including but not limited to tuberculosis, HIV, hepatitis, and syphilis 21. Clinically significant cardiovascular (e.g. history ...

8. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   Active tuberculosis. Severe infections within 4 weeks prior to randomization, including but not limited to hospitalization for complications of infection ...

9. A Study to Evaluate Pembrolizumab with Standard Therapy to Treat Newly-diagnosed Glioblastoma - Mayo Clinic

   Known history of active TB (Bacillus Tuberculosis). Received a live vaccine ≤ 30 days prior to registration. History of (non-infectious) pneumonitis that ...

10. A Study to Evaluate the Effectiveness and Safety of PCS499 in Treating Ulcerations in Patients who have Necrobiosis Lipoidica - Mayo Clinic

    History of or current diagnosis of active tuberculosis (TB); undergoing treatment for latent TB infection (LTBI); untreated LTBI (as determined by ...